Recent Patents on Drug Delivery & Formulation
Title:Anti-Cancer Products from Marine Sponges: Progress and Promise
Volume: 9 Issue: 3
Author(s): Abolfazl Shakeri and Amirhossein Sahebkar
Affiliation:
Export Options
About this article
Cite this article as:
Shakeri Abolfazl and Sahebkar Amirhossein, Anti-Cancer Products from Marine Sponges: Progress and Promise, Recent Patents on Drug Delivery & Formulation 2015; 9 (3) . https://dx.doi.org/10.2174/1872211309666150529131549
DOI https://dx.doi.org/10.2174/1872211309666150529131549 |
Print ISSN 1872-2113 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4039 |
40
4
Related Articles
-
Tc-99m Radiolabeled Alendronate Sodium Microemulsion: Characterization and Permeability Studies Across Caco-2 Cells
Current Drug Delivery Molecular Imaging of Apoptosis In Vivo with Scintigraphic and Optical Biomarkers – A Status Report
Anti-Cancer Agents in Medicinal Chemistry Antibacterial Peptides and Gastrointestinal Diseases
Current Pharmaceutical Design Impact of Nutrients on the Functioning of Intestinal Goblet Cells: Health and Therapeutic Perspectives
Current Nutrition & Food Science CXXC5 Associates with Smads to Mediate TNF-α Induced Apoptosis
Current Molecular Medicine Melanoma: Prognostic Factors and Factors Predictive of Response to Therapy
Current Medicinal Chemistry Adipose Tissue: Something More than Just Adipocytes
Current Nutrition & Food Science Cancer Stem Cells Stemness Transcription Factors Expression Correlates with Breast Cancer Disease Stage
Current Stem Cell Research & Therapy Oncomirs: From Tumor Biology to Molecularly Targeted Anticancer Strategies
Mini-Reviews in Medicinal Chemistry Antineoplastic Potential of Medicinal Plants
Recent Patents on Biotechnology Anticancer Studies of Leucovorin against Methotrexate Induced Genotoxicity in Swiss Albino Mice
Letters in Drug Design & Discovery The Cross-talk between Tristetraprolin and Cytokines in Cancer
Anti-Cancer Agents in Medicinal Chemistry Role of Metabolic Enzymes P450 (CYP) on Activating Procarcinogen and their Polymorphisms on the Risk of Cancers
Current Drug Metabolism Targeted Therapy of Ovarian Cancer with Angiogenesis Inhibitors
Current Drug Targets Pharmacokinetics and Disposition of Various Drug Loaded Biodegradable Poly(Lactide-Co-Glycolide) (PLGA) Nanoparticles
Current Drug Metabolism VEGF/VEGFR Pathway Inhibitors as Anti-Angiogenic Agents: Present and Future
Current Cancer Drug Targets Plant Cells as Pharmaceutical Factories
Current Pharmaceutical Design Biochemical Markers of Autoimmune Diseases of the Nervous System
Current Pharmaceutical Design The Anti-Inflammatory Role of Annexin-1 in Arthritis
Current Rheumatology Reviews The Genomic Approaches to Major Depression
Current Pharmacogenomics